Obesity and Benign Thyroid Conditions Increase Risk of Thyroid Cancer (01/19/2010)
Researchers affiliated with the U.S. Radiologic Technologists Study have reported that obesity and benign thyroid conditions increase the risk of thyroid cancer. The details of this study appeared in an early online publication in the American Journal of Epidemiology on November 30, 2009.

Zactima™ Has Significant Activity in Hereditary Medullary Thyroid Cancer (01/14/2010)
Researchers from the National Cancer Institute have reported that Zactima® (vandetanib) has significant activity for the treatment of patients with metastatic hereditary medullary thyroid cancer. The details of this study appeared in an early online publication on January 11, 2010 in the Journal of Clinical Oncology.

Alcohol May Reduce Risk of Thyroid Cancer (11/06/2009)
Researchers affiliated with the NIH-AARP Diet and Health Study have reported that alcohol intake may reduce the risk of thyroid cancer. The details of this study appeared in the November 4, 2009 issue of the British Journal of Cancer.

Childhood Cancer Survivors at Risk for Thyroid Cancer (11/05/2009)
Researchers from the UK have reported that survivors of childhood cancer are 18 times more likely to develop thyroid cancer than the general population. The details of this study appeared in the November 15, 2009 issue of the International Journal of Cancer.

Nexavar® Confirmed Effective for Patients with Advanced Thyroid Cancer (10/08/2009)
Researchers from the University of Pennsylvania have reported that Nexavar® (sorafenib) appears to have significant activity for patients with differentiated thyroid cancer (DTC). The details of this study were presented as a late-breaking abstract at the Joint ECCO 15 – 34^th ESMO Multidisciplinary Congress in Berlin, September 20-24, 2009.

▪ More...

Obesity and Benign Thyroid Conditions Increase Risk of Thyroid Cancer (01/19/2010)
Researchers affiliated with the U.S. Radiologic Technologists Study have reported that obesity and benign thyroid conditions increase the risk of thyroid cancer. The details of this study appeared in an early online publication in the American Journal of Epidemiology on November 30, 2009.

Zactima™ Has Significant Activity in Hereditary Medullary Thyroid Cancer (01/14/2010)
Researchers from the National Cancer Institute have reported that Zactima® (vandetanib) has significant activity for the treatment of patients with metastatic hereditary medullary thyroid cancer. The details of this study appeared in an early online publication on January 11, 2010 in the Journal of Clinical Oncology.

Alcohol May Reduce Risk of Thyroid Cancer (11/06/2009)
Researchers affiliated with the NIH-AARP Diet and Health Study have reported that alcohol intake may reduce the risk of thyroid cancer. The details of this study appeared in the November 4, 2009 issue of the British Journal of Cancer.

Childhood Cancer Survivors at Risk for Thyroid Cancer (11/05/2009)
Researchers from the UK have reported that survivors of childhood cancer are 18 times more likely to develop thyroid cancer than the general population. The details of this study appeared in the November 15, 2009 issue of the International Journal of Cancer.

Nexavar® Confirmed Effective for Patients with Advanced Thyroid Cancer (10/08/2009)
Researchers from the University of Pennsylvania have reported that Nexavar® (sorafenib) appears to have significant activity for patients with differentiated thyroid cancer (DTC). The details of this study were presented as a late-breaking abstract at the Joint ECCO 15 – 34^th ESMO Multidisciplinary Congress in Berlin, September 20-24, 2009.

▪ More...